UAE Intragastric Balloons Market, By Administration (Pill Form v/s Endoscopy), By Balloon Type (Single, Dual, Triple), By Filling Type (Saline Filled v/s Gas Filled), By Application (Obesity, Diabetes, Diet Control, Others), By End User (Hospitals &, Clin

UAE Intragastric Balloons Market, By Administration (Pill Form v/s Endoscopy), By Balloon Type (Single, Dual, Triple), By Filling Type (Saline Filled v/s Gas Filled), By Application (Obesity, Diabetes, Diet Control, Others), By End User (Hospitals &, Clinics, Ambulatory Surgical Centers, Others), By Region, Competition Forecast & Opportunities, 2027

The UAE intragastric balloons market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include the increasing prevalence of obesity, technological advancements, and customer preference for non-surgical and non-invasive procedures. An intragastric balloon is a saline-filled or gas-filled balloon that is placed inside the stomach to lose weight. It is inserted orally to restrict the amount of food stored by the stomach, thereby providing an early feeling of satiety. It also aids in eliminating other health-related concerns such as strokes, diabetes, and high blood pressure. Various advancements are made for optimal results and the reduction of associated difficulties. The other factors which are bolstering the market growth are changing lifestyles, increasing investments in the healthcare sector, growing awareness, and low price of intragastric balloon procedure.

Increasing Prevalence of Obesity

The increasing prevalence of obesity is one of the main reasons driving the growth of the market. Owing to a lack of inactivity, deskbound jobs, alcohol consumption, and unhealthy eating habits, a significant portion of the world's population is suffering from weight-related health concerns. Thus, many physicians advice patients to lose weight, and overweight and obese people opt for the intragastric balloons method, as it serves as an effective non-surgical procedure. As per the Central Intelligence Agency World Factbook, the UAE has an obesity prevalence rate of 31.7%.

Preference Towards Non-Surgical and Non-Invasive Procedures

Nowadays, due to an increase in awareness among the masses regarding weight-loss procedures, obese and overweight adults prefer non-surgical and non-invasive treatments, including intragastric balloons. Intragastric balloons serve as an effective non-surgical substitute for weight loss as they are inserted orally and do not require any incisions on the body. Also, it has a fast recovery rate with less discomfort. Likewise, the growing preference for non-invasive surgeries is bolstering market growth.

Technological Advancements

Technological advancements and product innovations are the key factors influencing the market. Manufacturers are focusing on creating product variants with minimal side effects, such as gastric erosion, ulceration, and nausea. The advancements are made in intragastric balloons by coupling dual and triple balloons to prevent the migration of the device from the stomach to the intestine, thus, in turn, reducing the risk of intestinal obstruction. They are also designing balloons with adjustable gas/saline volumes. In UAE, allurion Technologies announced the availability of its Gastric Balloon technology for people with age between 16 to 65 years in selected clinics, and it is the first and only weight loss tool in the world without surgery, endoscopy, or anesthesia.

Market Segmentation

The UAE Intragastric balloons market is segmented into administration, balloon type, filling type, application, end-user, and company. Based on administration, the market is divided into pill form and endoscopy. Based on balloon type, the market is divided into single, dual, and triple. Based on filling type, the market is divided into saline-filled and gas-filled. Based on application, the market is divided into obesity, diabetes, diet control, and others. Based on end-user, the market is divided into hospitals & clinics, ambulatory surgical centers, and others. In terms of region, the market is segmented into Abu Dhabi, Dubai, Sharjah, and Rest of UAE.

Market Players

Obalon Therapeutics, Inc. (UAE), Allurion Technologies, Inc. (UAE), ReShape Lifesciences Inc (UAE), Silimed Inc. (UAE), Allergan Middle East Limited, Vasmed UAE, and Life Mate Medical Equipment Trading LLC are some of the leading companies operating in the market.

Report Scope:

In this report, UAE intragastric balloons market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

• UAE Intragastric balloons Market, By Administration:
• Pill Form
• Endoscopy
• UAE Intragastric Balloons Market, By Balloon Type:
• Single
• Dual
• Triple
• UAE Intragastric balloons Market, By Filling Type:
• Saline Filled
• Gas Filled
• UAE Intragastric balloons Market, By Application:
• Obesity
• Diabetes
• Diet Control
• Others
• UAE Intragastric balloons Market, By End User:
• Hospitals & Clinics
• Ambulatory Care Centers
• Others
• UAE Intragastric balloons Market, By Region:
• Abu Dhabi
• Dubai
• Sharjah
• Rest of UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Intragastric balloons market.

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights